Month: December 2018

Washington University in St. Louis announced that its X-Calibur instrument, a telescope that measures the polarization of X-rays arriving from distant neutron stars, black holes and other exotic celestial bodies, launched from McMurdo Station, Antarctica.

A study from the School of Medicine suggests that people over 65 who are newly diagnosed with heart failure can continue to drink moderate amounts of alcohol without worsening their condition.

The legality, let alone the wisdom, of closing the southern border amid a partial government shutdown is called into question by Stephen Legomsky, an immigration-law expert at Washington University in St. Louis.

There is no secret to happiness, but there is a science to it, says Tim Bono, a psychology lecturer in Arts & Sciences who teaches courses on happiness at  Washington University in St. Louis.

The Source looks back at some of our most read and most shared stories of 2018. Highlights include good news (a new chancellor), bad news (even light drinking increases risk of death) and who knew news (“collective narcissism” is real and Virginians have it).

A new study from the School of Medicine shows that the common acne medication isotretinoin alters the microbiome of the skin. The study raises the possibility of developing microbiome-based acne treatments.

Margaret Garb, professor of history in Arts & Sciences and co-director of the Washington University Prison Education Project, died Dec. 15 after a long battle with cancer. She was 56.

It’s time to take a bold step forward. The United States has an opportunity to redefine itself as the country that protects the trust that people give to companies. By embracing trust, the United States can become a leader on privacy instead of following the path of false promises and diminishing returns.

Milica Banjanin, professor emerita of Russian in Arts & Sciences at Washington University in St. Louis, died Dec. 9. She was 79. A memorial will take place Feb. 17.

An international team, including faculty from the School of Engineering & Applied Science at Washington University in St. Louis, has used genetic phenotype to determine which patients would benefit the most from a commonly used drug treatment.